Trial of a Parenting Discussion Group in Panama, Central America

This study has been completed.
Sponsor:
Collaborator:
National Secretariat of Science, Technology and Innovation in Panama (SENACYT)
Information provided by (Responsible Party):
Anilena Mejia, University of Manchester
ClinicalTrials.gov Identifier:
NCT01771068
First received: January 11, 2013
Last updated: January 17, 2013
Last verified: January 2013
  Purpose

The present study aims to examine the effectiveness of a parenting intervention, the Triple P Positive Parenting Program Level 3 discussion groups "dealing with disobedience". Triple P is a system of interventions to support families and was developed at the University of Queensland in Australia in the 1980's. As few studies have tested the effectiveness of parenting programs in developing countries, the present study took place in a developing country, Panama.

In a recent study carried out in Australia, this same intervention was found effective in reducing child behaviour problems and the use of dysfunctional parenting (Morawska, Haslam, Milne & Sanders, 2011).


Condition Intervention
Child Behavioural and Emotional Difficulties
Parenting Practices
Behavioral: Triple P Positive Parenting Program Discussion Group "Dealing with Disobedience"

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by University of Manchester:

Primary Outcome Measures:
  • Change in Eyberg Child Behaviour Inventory (ECBI) [ Time Frame: baseline, 2 weeks post intervention, 3 months and 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change in Depression Anxiety Stress Scale 21 (DASS 21) [ Time Frame: baseline, 2 weeks post intervention, 3 months and 6 months ] [ Designated as safety issue: No ]
  • Change in Parenting Scale (PS) [ Time Frame: baseline, 2 weeks post intervention, 3 months and 6 months ] [ Designated as safety issue: No ]
  • Change in Parenting Task Checklist (PTC) [ Time Frame: baseline, 2 weeks post intervention, 3 months and 6 months ] [ Designated as safety issue: No ]

Enrollment: 108
Study Start Date: April 2012
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Waiting list
Experimental: Parenting Discussion Group
Two-hour discussion group on child noncompliance. Groups were composed by a maximum of 10 parents and were facilitated by the principal researcher, who is an accredited practitioner. The groups were interactive and discussion based, and a power point presentation with embedded-video clips was used to aid the facilitator. The key points covered in the discussion group included reasons for disobedience, parenting traps, encouraging good behaviour, and managing disobedience. Parents also received a workbook that included the content covered in the discussion group and 2 follow up telephone calls to check how they were doing after the discussion groups.
Behavioral: Triple P Positive Parenting Program Discussion Group "Dealing with Disobedience"

Detailed Description:

This is a randomized controlled trial (RCT) with two groups (waiting list versus Triple P discussion groups) and measurements at pre-intervention, post intervention, three and six months follow up.

The intervention trialed was a 2-hour, one-session discussion group on child noncompliance. Groups were composed by a maximum of 10 parents and were facilitated by the principal researcher, who is an accredited practitioner. The groups were interactive and discussion based, and a power point presentation with embedded-video clips were used to aid the facilitator. The key points that were covered in the discussion group included reasons for disobedience, parenting traps, encouraging good behaviour, and managing disobedience. Parents also received a workbook that included the content covered in the discussion group and 2 follow up telephone calls to check how they were doing after.

Participants were randomly assigned to a treatment group (Triple P discussion groups) or to a waiting list group. A statistician independent from the research team generated a random list of numbers. Randomization was stratified based on the level of child behavioural difficulties (high or low) measured at baseline. In order to ensure allocation concealment, sequentially-numbered, opaque, sealed envelopes (SNOSE) were opened after participants agreed to take part in the study and completed a baseline assessment. After randomization, those assigned to the waiting list group were assessed at time 1 (baseline) and then 4 weeks, 3 months and 6 months after the first assessment. Those assigned to the treatment group were assessed at time 1 (baseline), 2 weeks, 3 months and 6 months after the intervention. Assessments were carried out by a research assistant who was blind to group allocation.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Participants must be Panamanian
  • must have at least one child between 3 and 12 years old
  • must report some level of difficulty in dealing with their child behaviour.

Exclusion Criteria:

  • no report of difficulty in dealing with child behaviour
  • illiteracy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01771068

Locations
Panama
Ministry of Education, District of Panama
Panama, Panama
Sponsors and Collaborators
University of Manchester
National Secretariat of Science, Technology and Innovation in Panama (SENACYT)
Investigators
Principal Investigator: Anilena Mejia, MSc The University of Manchester
Principal Investigator: Rachel Calam, Professor The University of Manchester
Principal Investigator: Matthew Sanders, Professor The University of Queensland
  More Information

No publications provided

Responsible Party: Anilena Mejia, PhD Student, University of Manchester
ClinicalTrials.gov Identifier: NCT01771068     History of Changes
Other Study ID Numbers: PTY12
Study First Received: January 11, 2013
Last Updated: January 17, 2013
Health Authority: United Kingdom: Research Ethics Committee

ClinicalTrials.gov processed this record on July 29, 2014